Cargando…
Stem Cell-Based Disease Models for Inborn Errors of Immunity
The intrinsic capacity of human hematopoietic stem cells (hHSCs) to reconstitute myeloid and lymphoid lineages combined with their self-renewal capacity hold enormous promises for gene therapy as a viable treatment option for a number of immune-mediated diseases, most prominently for inborn errors o...
Autores principales: | Zbinden, Aline, Canté-Barrett, Kirsten, Pike-Overzet, Karin, Staal, Frank J. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750661/ https://www.ncbi.nlm.nih.gov/pubmed/35011669 http://dx.doi.org/10.3390/cells11010108 |
Ejemplares similares
-
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
por: Garcia-Perez, Laura, et al.
Publicado: (2020) -
Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?
por: Jridi, Imen, et al.
Publicado: (2021) -
Multi-omic analyses in immune cell development with lessons learned from T cell development
por: Cordes, Martijn, et al.
Publicado: (2023) -
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
por: Klaver-Flores, Stefanie, et al.
Publicado: (2021) -
Advances in gene therapy for inborn errors of immunity
por: Ott de Bruin, Lisa M., et al.
Publicado: (2023)